Business · 26/07/2017
FDA Releases Guidance on Generic Drug User Fee Amendments of 2012
The FDA has released a guidance document addressing questions and answers related to the Generic Drug User Fee Amendments of 2012, aiming to improve the review process for generic drugs and enhance the delivery of safe and effective generic products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →